Daniel O'Day becomes Gilead Sciences CEO

Source: Dukascopy Bank SA
Daniel O'Day, the head of Roche Holding AG's pharmaceuticals business, became the new CEO of drug manufacturer Gilead Sciences Inc.
Back to articles

Actual Topics

Mon, 10 Dec 2018 10:44:40 GMT

Huawei CFO hearing continues

On Monday, the hearing of the detained Huawei CFO in Canada resumed. Meanwhile, Chinese officials were increasing pressure on Canada to release the CFO.

Mon, 10 Dec 2018 10:02:29 GMT

Euro Zone investors' confidence drops to four-year minimum

According to survey data published on Monday, the Euro Zone investors' sentiment dropped from 8.8 in November to -0.3 in December, thus reaching a four-year low.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.